STOCK TITAN

[8-K] HF Foods Group Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

HF Foods Group, Inc. entered into a Sales Agreement on September 25, 2025 with D.A. Davidson & Co. and Roth Capital Partners to sell shares of common stock in an "at-the-market" offering under its effective Form S-3 (File No. 333-281918). Under the related prospectus supplement dated September 25, 2025, the Company may offer and sell up to $100 million of common stock from time to time. Sales will be made through or to the Sales Agents, including directly on Nasdaq or other trading markets, with compensation to the agents of up to 3.0% of gross proceeds. The Company may use proceeds for general corporate purposes, including capital expenditures, possible acquisitions, expansion and working capital. The Company is not obligated to sell any shares, and the agreement includes customary expense reimbursement, indemnification, contribution provisions and termination mechanics.

HF Foods Group, Inc. ha stipulato un Accordo di Vendita il 25 settembre 2025 con D.A. Davidson & Co. e Roth Capital Partners per vendere azioni ordinarie in un’offerta di tipo "at-the-market" ai sensi del suo Form S-3 efficace (File No. 333-281918). Secondo il relativo supplemento al prospetto datato 25 settembre 2025, la Società può offrire e vendere fino a $100 milioni di azioni ordinarie di volta in volta. Le vendite saranno effettuate tramite o ai Sales Agents, compresi direttamente su Nasdaq o altri mercati di negoziazione, con una commissione per gli agenti fino al 3,0% dei proventi lordi. La Società può utilizzare i proventi per scopi generali aziendali, inclusi investimenti in capitale, possibili acquisizioni, espansione e capitale circolante. La Società non è obbligata a vendere azioni e l’accordo comprende consuete disposizioni di rimborso spese, indennizzo, contributo e meccanismi di risoluzione.

HF Foods Group, Inc. suscribió un Acuerdo de Venta el 25 de septiembre de 2025 con D.A. Davidson & Co. y Roth Capital Partners para vender acciones ordinarias en una oferta de mercado continuo bajo su Form S-3 vigente (Archivo No. 333-281918). Según el suplemento de prospecto relacionado fechado el 25 de septiembre de 2025, la Compañía puede ofrecer y vender hasta $100 millones de acciones ordinarias de vez en cuando. Las ventas se realizarán a través o a los Agentes de Venta, incluso directamente en Nasdaq u otros mercados de negociación, con una compensación para los agentes de hasta 3.0% de los ingresos brutos. La Compañía puede utilizar los ingresos para fines corporativos generales, incluyendo gastos de capital, posibles adquisiciones, expansión y capital de trabajo. La Compañía no está obligada a vender acciones, y el acuerdo incluye cláusulas habituales de reembolso de gastos, indemnización, disposiciones de contribución y mecanismos de terminación.

HF Foods Group, Inc.는 2025년 9월 25일 D.A. Davidson & Co. 및 Roth Capital Partners와 주당 일반주를 시장가 매도형(offering)으로 판매하기 위한 매매계약(Sales Agreement)을 체결했습니다. 이 계약은 유효한 Form S-3(파일 번호 333-281918)에 따른 것으로, 2025년 9월 25일자 관련 프로스펙투스 보충서에 따라 회사는 시기에 따라 최대 $100 million의 일반주를 매도할 수 있습니다. 매매는 Nasdaq 또는 기타 거래시장에서도 직접 진행될 수 있으며, 매매대리인에게 지급되는 보상은 최대 총매출의 3.0%까지입니다. 회사는 자본지출, 잠재적 인수, 확장 및 운전자본 등 일반 사업 목적을 위해 자금을 사용할 수 있습니다. 회사는 주식을 매도할 의무가 없으며, 계약에는 일반적인 경비상환, 면책, 기여 조항 및 해지 메커니즘이 포함됩니다.

HF Foods Group, Inc. a passé un accord de vente le 25 septembre 2025 avec D.A. Davidson & Co. et Roth Capital Partners pour vendre des actions ordinaires dans une offre de marché (at-the-market) conformément à son Form S-3 en vigueur (Numéro de fichier 333-281918). En vertu du supplément de prospectus lié daté du 25 septembre 2025, la Société peut offrir et vendre jusqu’à $100 millions d’actions ordinaires de temps à autre. Les ventes seront réalisées par ou vers les Agents de Vente, y compris directement sur Nasdaq ou d’autres marchés, avec une compensation pour les agents pouvant aller jusqu’à 3,0% des produits bruts. La Société peut utiliser les produits pour des besoins généraux de l’entreprise, y compris dépenses en capital, acquisitions possibles, expansion et fonds de roulement. La Société n’est pas obligée de vendre des actions et l’accord comprend des dispositions habituelles de remboursement des dépenses, d’indemnisation, de contributions et des mécanismes de résiliation.

HF Foods Group, Inc. hat am 25. September 2025 eine Verkaufsvereinbarung mit D.A. Davidson & Co. und Roth Capital Partners getroffen, um Aktien des Stammkapitals in einem "at-the-market"-Angebot gemäß dem gültigen Form S-3 (Datei Nr. 333-281918) zu verkaufen. Gemäß dem zugehörigen Prospektzusatz vom 25. September 2025 kann das Unternehmen von Zeit zu Zeit bis zu $100 Millionen Stammaktien anbieten und verkaufen. Die Verkäufe erfolgen durch oder an die Verkaufsvertreter, einschließlich direkt an der Nasdaq oder anderen Handelsmärkten, wobei die Vermittler bis zu 3,0% des Bruttoertrages erhalten. Die Mittel können für allgemeine Geschäftszwecke verwendet werden, einschließlich Investitionen in Sachanlagen, mögliche Übernahmen, Expansion und working capital. Das Unternehmen ist nicht verpflichtet, Aktien zu verkaufen, und die Vereinbarung enthält übliche Erstattung von Aufwendungen, Haftungsfreistellung, Beitragsbestimmungen und Beendigungsmechanismen.

HF Foods Group, Inc. أبرمت اتفاقية بيع في 25 سبتمبر 2025 مع شركة D.A. Davidson & Co. وشركة Roth Capital Partners لبيع أسهم عادية في عرض "at-the-market" بموجب نموذج S-3 الفعال الخاص بها (الملف رقم 333-281918). وفقًا للمُلحق المتعلقة بالنشرة الإرشادية المؤرخة في 25 سبتمبر 2025، قد تعرض الشركة وتبيع حتى $100 مليون من الأسهم العادية بين الحين والآخر. ستُجرى المبيعات من خلال وكلاء المبيعات، بما في ذلك بشكل مباشر على Nasdaq أو أسواق تداول أخرى، مع تعويض للوكلاء يصل إلى 3.0% من الإيرادات الإجمالية. يجوز للشركة استخدام العائدات للأغراض العامة للشركة، بما في ذلك النفقات الرأسمالية، والاندماجات المحتملة، والتوسع، ورأسمال العمل. ليست الشركة ملزمة ببيع أي أسهم، ويتضمن الاتفاق أحكامًا اعتيادية لاسترداد النفقات والتعويض والمساهمات وآليات الإنهاء.

HF Foods Group, Inc. 于2025年9月25日与D.A. Davidson & Co.及Roth Capital Partners签订销售协议,以在其有效的表格S-3(文件编号333-281918)下进行“市值)在市市场”发行来出售普通股。根据相关的面向2025年9月25日的招股说明书增补,公司可在不定期地出售最高至$100百万的普通股。销售将通过或向销售代理进行,包括直接在纳斯达克或其他交易市场上进行,代理人佣金最高为毛收益的3.0%。公司可将收益用于一般企业用途,包括资本支出、潜在并购、扩张和运营资金。公司并非有义务出售任何股票,协议包含常规费用报销、赔偿、互助条款及终止机制。

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Company establishes a $100M at-the-market equity program with up to 3% selling commissions; proceeds earmarked for general corporate purposes.

This Sales Agreement formalizes an at-the-market (ATM) capability under the Company’s effective Form S-3, enabling incremental equity issuance up to $100 million over time. The arrangement provides financing optionality without immediate dilution unless shares are actually sold. Agent compensation of up to 3.0% is disclosed, along with customary expense reimbursements and indemnities. The filing does not state any planned timing, target amounts, or pricing for sales, so material near-term capital impact cannot be quantified from this disclosure alone.

TL;DR: Standard ATM Sales Agreement with customary indemnities and termination provisions; no mandatory issuance obligations.

The Sales Agreement includes typical contractual protections for placement agents, including indemnification and expense reimbursement, and allows termination on short notice by either party. The agreement is incorporated by reference and the legal opinion of counsel is filed as an exhibit. The filing provides procedural detail but does not commit the company to any share issuance, preserving board and management discretion over future equity raises.

HF Foods Group, Inc. ha stipulato un Accordo di Vendita il 25 settembre 2025 con D.A. Davidson & Co. e Roth Capital Partners per vendere azioni ordinarie in un’offerta di tipo "at-the-market" ai sensi del suo Form S-3 efficace (File No. 333-281918). Secondo il relativo supplemento al prospetto datato 25 settembre 2025, la Società può offrire e vendere fino a $100 milioni di azioni ordinarie di volta in volta. Le vendite saranno effettuate tramite o ai Sales Agents, compresi direttamente su Nasdaq o altri mercati di negoziazione, con una commissione per gli agenti fino al 3,0% dei proventi lordi. La Società può utilizzare i proventi per scopi generali aziendali, inclusi investimenti in capitale, possibili acquisizioni, espansione e capitale circolante. La Società non è obbligata a vendere azioni e l’accordo comprende consuete disposizioni di rimborso spese, indennizzo, contributo e meccanismi di risoluzione.

HF Foods Group, Inc. suscribió un Acuerdo de Venta el 25 de septiembre de 2025 con D.A. Davidson & Co. y Roth Capital Partners para vender acciones ordinarias en una oferta de mercado continuo bajo su Form S-3 vigente (Archivo No. 333-281918). Según el suplemento de prospecto relacionado fechado el 25 de septiembre de 2025, la Compañía puede ofrecer y vender hasta $100 millones de acciones ordinarias de vez en cuando. Las ventas se realizarán a través o a los Agentes de Venta, incluso directamente en Nasdaq u otros mercados de negociación, con una compensación para los agentes de hasta 3.0% de los ingresos brutos. La Compañía puede utilizar los ingresos para fines corporativos generales, incluyendo gastos de capital, posibles adquisiciones, expansión y capital de trabajo. La Compañía no está obligada a vender acciones, y el acuerdo incluye cláusulas habituales de reembolso de gastos, indemnización, disposiciones de contribución y mecanismos de terminación.

HF Foods Group, Inc.는 2025년 9월 25일 D.A. Davidson & Co. 및 Roth Capital Partners와 주당 일반주를 시장가 매도형(offering)으로 판매하기 위한 매매계약(Sales Agreement)을 체결했습니다. 이 계약은 유효한 Form S-3(파일 번호 333-281918)에 따른 것으로, 2025년 9월 25일자 관련 프로스펙투스 보충서에 따라 회사는 시기에 따라 최대 $100 million의 일반주를 매도할 수 있습니다. 매매는 Nasdaq 또는 기타 거래시장에서도 직접 진행될 수 있으며, 매매대리인에게 지급되는 보상은 최대 총매출의 3.0%까지입니다. 회사는 자본지출, 잠재적 인수, 확장 및 운전자본 등 일반 사업 목적을 위해 자금을 사용할 수 있습니다. 회사는 주식을 매도할 의무가 없으며, 계약에는 일반적인 경비상환, 면책, 기여 조항 및 해지 메커니즘이 포함됩니다.

HF Foods Group, Inc. a passé un accord de vente le 25 septembre 2025 avec D.A. Davidson & Co. et Roth Capital Partners pour vendre des actions ordinaires dans une offre de marché (at-the-market) conformément à son Form S-3 en vigueur (Numéro de fichier 333-281918). En vertu du supplément de prospectus lié daté du 25 septembre 2025, la Société peut offrir et vendre jusqu’à $100 millions d’actions ordinaires de temps à autre. Les ventes seront réalisées par ou vers les Agents de Vente, y compris directement sur Nasdaq ou d’autres marchés, avec une compensation pour les agents pouvant aller jusqu’à 3,0% des produits bruts. La Société peut utiliser les produits pour des besoins généraux de l’entreprise, y compris dépenses en capital, acquisitions possibles, expansion et fonds de roulement. La Société n’est pas obligée de vendre des actions et l’accord comprend des dispositions habituelles de remboursement des dépenses, d’indemnisation, de contributions et des mécanismes de résiliation.

HF Foods Group, Inc. hat am 25. September 2025 eine Verkaufsvereinbarung mit D.A. Davidson & Co. und Roth Capital Partners getroffen, um Aktien des Stammkapitals in einem "at-the-market"-Angebot gemäß dem gültigen Form S-3 (Datei Nr. 333-281918) zu verkaufen. Gemäß dem zugehörigen Prospektzusatz vom 25. September 2025 kann das Unternehmen von Zeit zu Zeit bis zu $100 Millionen Stammaktien anbieten und verkaufen. Die Verkäufe erfolgen durch oder an die Verkaufsvertreter, einschließlich direkt an der Nasdaq oder anderen Handelsmärkten, wobei die Vermittler bis zu 3,0% des Bruttoertrages erhalten. Die Mittel können für allgemeine Geschäftszwecke verwendet werden, einschließlich Investitionen in Sachanlagen, mögliche Übernahmen, Expansion und working capital. Das Unternehmen ist nicht verpflichtet, Aktien zu verkaufen, und die Vereinbarung enthält übliche Erstattung von Aufwendungen, Haftungsfreistellung, Beitragsbestimmungen und Beendigungsmechanismen.

0001680873false00016808732025-09-252025-09-250001680873us-gaap:CommonStockMember2025-09-252025-09-250001680873us-gaap:PreferredStockMember2025-09-252025-09-25

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 25, 2025

HF FOODS GROUP INC.
(Exact name of registrant as specified in its charter)
Delaware 
State or other Jurisdiction of
    incorporation )  
001-38180
(Commission
File No.)
81-2717873
(IRS Employer
Identification No)
6325 South Rainbow Boulevard, Suite 420
Las Vegas, Nevada
(Address of principal executive offices)
 
89118
(Zip Code)

Registrant’s telephone number, including area code: (888)-905-0998

Not Applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, $0.0001 par valueHFFG
Nasdaq Capital Market
Preferred Share Purchase Rights
N/A
Nasdaq Capital Market


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company     


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐







Item 1.01.    Entry into a Material Definitive Agreement

On September 25, 2025, HF Foods Group, Inc. (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with D.A. Davidson & Co. and Roth Capital Partners, LLC (the “Sales Agents”), pursuant to which the Company may sell, from time to time, at its option, shares (the “Shares”) of the Company’s common stock through or to the Sales Agents. The issuance and sale, if any, of shares of the Company's common stock under the Sales Agreement will be pursuant to the Company's registration statement on Form S-3 (File No. 333-281918), which became effective on September 17, 2024, and the related prospectus supplement dated September 25, 2025 (the "Prospectus Supplement"), in each case filed with the U.S. Securities and Exchange Commission (the "SEC"). In accordance with the terms of the Sales Agreement, under the Prospectus Supplement, the Company may offer and sell shares of its common stock having an aggregate offering price of up to $100 million from time to time through the Sales Agents. The Company intends to use the proceeds from any sales for general corporate purposes which may include, among other things, funding capital expenditures, paying for possible acquisitions or the expansion of our business, and general working capital purposes.

The sale, if any, of shares of the Company's common stock under the Sales Agreement will be made by any method permitted that is deemed to be an "at-the-market" equity offering as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), including sales made directly on the Nasdaq Capital Market or any other trading market for the Company's common stock. Subject to the terms and conditions of the Sales Agreement, the Sales Agents will use commercially reasonable efforts to sell the shares of the Company's common stock from time to time, based upon the Company's instructions.

The compensation payable to the Sales Agents shall be up to 3.0% of the gross sales price of the shares sold through or to the Sales Agents pursuant to the Sales Agreement. In addition, the Company will reimburse the Sales Agents for certain expenses incurred in connection with the Sales Agreement, and the Company has agreed in the Sales Agreement to provide indemnification and contribution to the Sales Agents against certain liabilities, including liabilities under the Securities Act.
The Company is not obligated to make any sales of shares of common stock under the Sales Agreement. The offering of common stock pursuant to the Sales Agreement will terminate upon (a) the election of the Sales Agents upon the occurrence of certain adverse events, (b) five business days’ advance notice from the Company to the Sales Agents or five days’ advance notice from any of the Sales Agents to the Company or (c) otherwise by mutual agreement of the parties pursuant to the terms of the Sales Agreement.

The Sales Agreement is attached to this Current Report on Form 8-K as Exhibit 10.1 and is incorporated herein by reference. The foregoing description of the material terms of the Sales Agreement does not purport to be complete and is qualified in its entirety by reference to the exhibit attached hereto.

The representations, warranties and covenants contained in the Sales Agreement were made solely for the benefit of the parties to the Sales Agreement, and may be subject to limitations agreed upon by the contracting parties. Accordingly, the Sales Agreement is incorporated herein by reference only to provide investors with information regarding the terms of the Sales Agreement and not to provide investors with any other factual information regarding the Company or its business, and should be read in conjunction with the disclosures in the Company’s periodic reports and other filings with the SEC.

The legal opinion of Akerman LLP relating to the shares of common stock being offered pursuant to the Sales Agreement is filed as Exhibit 5.1 to this Current Report on Form 8-K.

This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the common stock discussed herein, nor shall there be any offer, solicitation, or sale of the common stock in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.






Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.
Description
5.1
Opinion of Akerman LLP
10.1
Sales Agreement, by and among HF Foods Group Inc., D.A. Davidson & Co. and Roth Capital Partners, LLC, dated September 25, 2025*
23.1
Consent of Akerman LLP (contained in Exhibit 5.1)
99.1
Press Release, dated September 25, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)

*Certain portions of this exhibit have been omitted in accordance with Regulation S-K Item 601(b)(10)(iv) because they are both (i) not material to investors and (ii) the type of information that the Company customarily and actually treats as private or confidential, and have been marked with ‘‘[***]’’ to indicate where omissions have been made. The Company agrees to furnish supplementally an unredacted copy of the exhibit to the SEC upon its request.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

HF FOODS GROUP INC.
Date: September 25, 2025
/s/ Cindy Yao
Cindy Yao
Chief Financial Officer

Hf Foods Group Inc

NASDAQ:HFFG

HFFG Rankings

HFFG Latest News

HFFG Latest SEC Filings

HFFG Stock Data

185.94M
41.74M
24.12%
21.1%
0.91%
Food Distribution
Wholesale-groceries & Related Products
Link
United States
LAS VEGAS